Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Kenvue Stock: Is KVUE Underperforming the Consumer Defensive Sector?

December 05, 2025 at 10:07 AM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

With a market cap of $32.5 billion, Kenvue Inc. (KVUE) is a global consumer health company serving markets across the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three main segments: Self Care, Skin Health and Beauty, and Essential Health.

Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Kenvue fits this criterion perfectly. The company’s portfolio includes well-known brands such as Tylenol, Neutrogena, Listerine, and Johnson’s.

More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.

Shares of the Summit, New Jersey-based company have pulled back 32.7% from its 52-week high of $25.17. Shares of Kenvue have declined 9.5% over the past three months, lagging behind the Consumer Staples Select Sector SPDR Fund’s (XLP) 3.1% decrease over the same time frame.

Longer term, KVUE stock is down 21.1% on a YTD basis, underperforming XLP’s marginal dip. Moreover, shares of Kenvue have dipped 27.2% over the past 52 weeks, compared to XLP’s 5.4% drop over the same time frame.

The stock has been trading below its 50-day and 200-day moving averages since June.

Shares of KVUE climbed 12.3% on Nov. 3 after the company reported Q3 2025 results, including adjusted EPS of $0.28 and reaffirmed full-year 2025 guidance with adjusted EPS of $1 - $1.05. Investors also reacted positively to improving profitability metrics, such as gross profit margin rising to 59.1% and adjusted gross profit margin increasing to 61.2%, despite a 3.5% decline in net sales.

In comparison, rival The Procter & Gamble Company (PG) has shown less pronounced decline than KVUE stock. Shares of Procter & Gamble have decreased 17.8% over the past 52 weeks and 13.7% on a YTD basis.

Due to the stock’s weak performance, analysts are cautious about its prospects. The stock has a consensus rating of “Hold” from the 12 analysts covering the stock, and the mean price target of $19 is a premium of 12.1% to current levels.

On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

More news from Barchart

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol

Price

Change (%)

AMZN

271.58

+36.08 (15.32%)

AAPL

308.91

-24.52 (-7.35%)

AMD

476.15

-9.24 (-1.90%)

BAC

61.95

+0.22 (0.36%)

GOOG

356.65

+22.97 (6.88%)